← Back to Search

Other

Treatment Group (Hand Sanitizer) for Viruses

Q: Are there any open slots for participants in this medical trial?

As evidenced by the information available on clinicaltrials.gov, this experiment is currently searching for participants. The trial was first announced on April 8th 2022 and most recently updated November 13th 2023.

Q: How many participants have enrolled in the experiment?

Correct. According to clinicaltrials.gov, this medical trial is actively enrolling participants, having first been posted on the 8th of April 2022 and last updated on 13th November 2023. This trial requires a total of 20 volunteers from 3 distinct research sites.

Q: Are applicants who are 75 years or younger admissible to this clinical trial?

This clinical trial is open to patients aged 18-99, however there are separate trials for those under the age of 18 and over 65. Specifically, seven studies cater to minors and twenty six focus on elderly individuals.

Q: Can I qualify for this clinical experiment?

Those eligible for enrollment in the study must have a viral infection and be between 18 to 99 years of age. A maximum of 20 individuals will be included as participants.

Phase < 1

Recruiting

Research Sponsored by Leciel Bono

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-14 days

Awards & highlights

Study Summary

This trial will test if using Purell hand sanitizer can reduce the size, pain, and discomfort of HSV-1 (herpes) lesions and shorten their duration.

Eligible Conditions

Herpes
Viruses
Herpes Simplex Virus
Cold Sores

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-14 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-14 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Duration of HSV-1 Lesion

Secondary outcome measures

Level of Discomfort during Treatment

Level of Pain during Treatment

Size of Lesion during Treatment

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment Group (Hand Sanitizer)Experimental Treatment1 Intervention

Participants with an early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom), with the visible manifestation of a lesion will be invited to participate in the study. Participants will apply a large drop of hand sanitizer in an unmarked container to a Q-tip and will hold the Q-tip on the lesion for 10 seconds. The hand sanitizer will be administered every waking hour in the same manner.

Group II: Control Group (Medical Grade Mineral Oil)Placebo Group1 Intervention

Participants with an early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom), with the visible manifestation of a lesion will be invited to participate in the study. Participants will apply a large drop of Medical Grade Mineral Oil in an unmarked container to a Q-tip and will hold the Q-tip on the HSV-1 lesion for 10 seconds. The medical grade mineral oil will be administered every waking hour in the same manner.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Leciel BonoLead Sponsor

Leciel Bono, MSStudy ChairIdaho State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for participants in this medical trial?

"As evidenced by the information available on clinicaltrials.gov, this experiment is currently searching for participants. The trial was first announced on April 8th 2022 and most recently updated November 13th 2023."

Answered by AI

How many participants have enrolled in the experiment?

"Correct. According to clinicaltrials.gov, this medical trial is actively enrolling participants, having first been posted on the 8th of April 2022 and last updated on 13th November 2023. This trial requires a total of 20 volunteers from 3 distinct research sites."

Answered by AI

Are applicants who are 75 years or younger admissible to this clinical trial?

"This clinical trial is open to patients aged 18-99, however there are separate trials for those under the age of 18 and over 65. Specifically, seven studies cater to minors and twenty six focus on elderly individuals."

Answered by AI

Can I qualify for this clinical experiment?

"Those eligible for enrollment in the study must have a viral infection and be between 18 to 99 years of age. A maximum of 20 individuals will be included as participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Hand Sanitizer Use for Herpes Simplex Virus-1

Leciel Bono 2022. "Hand Sanitizer Use for Herpes Simplex Virus-1". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06135844.